乳腺癌患者甲状腺超声影像的占位性改变
Clinical Study on Thyroid Space Occupying Lesion by Ultrasound in Patients with Breast Cancer
-
摘要: 目的 探讨乳腺癌患者甲状腺超声影像占位性改变的发生情况.方法 回顾分析2008年10月至2012年9月明确诊断乳腺癌患者150例,与同期非乳腺癌患者150例做对照,通过超声影像改变对比,分析乳腺癌患者甲状腺影像占位性改变的发生情况.结果 乳腺癌患者与非乳腺癌患者比较,甲状腺伴有超声影像占位性改变增高(P<0.05),罹患甲状腺癌的例数增高(P<0.05).结论 乳腺癌患者的甲状腺影像占位性改变发生率高于非乳腺癌者.Abstract: Objective To investigate the incidence of thyroid space occupying lesion by ultrasound imaging in patients with breast cancer. Methods From 2009 to 2012,150 patients with breast cancer as experimental group and another 150 patients with breast benign diseases as control group underwent thyroid ultrasound examination. Ultrasound results of the two groups were analyzed to find the differences. Result More obvious space occupying lesions were found in experimental group than those in control group(P<0.05). Conclusion The incidence rate of thyroid space occupying lesion in the patients with breast cancer is higher than that in the patients with no breast cancer.
-
Key words:
- Breast cancer /
- Thyroid /
- Ultrasound
-
[1]禚守荣,杨小青.乳腺癌患者再发甲状腺癌临床分析[J].中国卫生标准管理,2014,5(3):9-11. [2] [2]PARK J S,OH K K,KIM E K,et al.Sonographic detection of thyroid cancer in breast cancer patients[J].Yonsei Med J,2007,48(1):63-68. [3]石臣磊,秦华东,石铁锋.乳腺癌并发甲状腺癌的超声诊断价值[J].医学临床研究,2010,27(7):1216-1218. [4] [4]JIANBO HUANG,LIAGBIN JIN,GUANGYAN J I,et al.Implication from thyroid function decreasing during chemotherapy in breast cancer patients:chemosensitization role of triiodothyronine[J].BMC Cancer J,2013,13(1):1-12. [5] [5]CHANG MIN PARK,YOUNG DON LEE,EUN MEE O H,et al.The prognosis and treatment of primary thyroid cancer occurred in breast cancer patients:comparison with ordinary thyroid cancer[J].Annals of Surgical Treatment and Research J,2014,86(4):169-176. [6] [6]MELISSA Z,BRAGANZA,AMY BERRINGTON DE GONZALEZ,et al.Benign breast and gynecological conditions,reproductive and hormonal factors,and risk of thyroid cancer[J].Cancer Prev Res(Phila),2014,7(4):418-425. [7] [7]LI LIU,JING S HI,FENGFENG MAO,et al.Synchronous primary cancers of the thyroid and breast:A case report and review of the literature[J].Oncology Letters,2015,9(1):351-354. [8] [8]DE GROOT S,JANSSEN L G,CHAREHBILI A,et al.Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients:results from the NEOZOTAC trial(BOOG 2010-01)[J].Breast Cancer Res Treat,2015,149(2):461-466. [9] [9]HALL L C,SALAZAR E P,KANE S R,et al.Effects of thyroid hormones on human breast cancer cell proliferation[J].J Steroid Biochem Mol Biol,2008,109(5):57-66. [10]陈剑吴毅.甲状腺癌与乳腺癌关系的研究进展[J].中国癌症志杂志,2011,21(2):138-152. [11]李波季洪亮梁青山.甲状腺疾病和乳腺癌相关性研究的进展[J].国际外科学杂志,2011,1138(11):751-754. [12]梅怡,冯雯,奉典旭.乳腺癌患者的甲状腺功能研究[J].研究论文,2011,32(12):735-737. [13]张立,昊万敏,刘志平.乳腺癌与甲状腺病变关系的研究进展[J].医学综述,2009,15(24):3693-3695. [14]温芬朱丽萍乳腺癌与甲状腺疾病的关系[J].国际肿瘤学杂志,2013,40(3):200-203. [15]赵艳杰王睿斌宋雨等乳腺癌与甲状腺疾病相关性的临床研究[J].肿瘤与临床,2013,25(3):178-180. [16] [16]FUNAKOSHI T,SHIMADA Y J.Risk of hypothyroidism in patients with cancer treated with sunitinib:a systematic review and meta-analysis[J].Acta Oncol,2013,52(4):691-702.
点击查看大图
计量
- 文章访问数: 3040
- HTML全文浏览量: 1135
- PDF下载量: 69
- 被引次数: 0